Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC by Garassino, Marina C., MD, Gadgeel, Shirish, XX, Novello, Silvia, XX, Halmos, Balazs, XX, Felip, Enriqueta, XX, Speranza, Giovanna, XX, Hui, Rina, XX, Garon, Edward B., XX, Horinouchi, Hidehito, XX, Sugawara, Shunichi, XX, Rodriguez-Abreu, Delvys, XX, Reck, Martin, XX, Cristescu, Razvan, XX, Aurora-Garg, Deepti, XX, Loboda, Andrey, XX, Lunceford, Jared, XX, Kobie, Julie, XX, Ayers, Mark, XX, Piperdi, Bilal, XX, Pietanza, M. Catherine, XX, Paz-Ares, Luis, XX

Get full text

RELAY+: Exploratory Study of Ramucirumab Plus Gefitinib in Untreated Patients With EGFR-Mutated Metastatic NSCLC by Nishio, Makoto, MD, PhD, Nishio, Kazuto, MD, PhD, Reck, Martin, MD, PhD, Garon, Edward B., MD, Imamura, Fumio, MD, PhD, Kawaguchi, Tomoya, PhD, Yamaguchi, Hiroyuki, MD, PhD, Ikeda, Satoshi, MD, PhD, Hirano, Katsuya, MD, Visseren-Grul, Carla, MD, Ceccarelli, Matteo, PharmD, MS, Wijayawardana, Sameera R., PhD, Zimmermann, Annamaria, MS, Matsui, Tomoko, XX, Enatsu, Sotaro, MD, PhD, Nakagawa, Kazuhiko, MD, PhD

Get full text

Investigation of Combination Treatment With an Aromatase Inhibitor Exemestane and Carboplatin-Based Therapy for Postmenopausal Women With Advanced NSCLC by Young, Patricia A., MD, Márquez-Garbán, Diana C., MD, Noor, Zorawar Singh, MD, Moatamed, Neda, MD, Elashoff, David, PhD, Grogan, Tristan, PhD, Romero, Tahmineh, PhD, Sasano, Hironobu, MD, PhD, Saito, Ryoko, XX, Rausch, Rebecca, PhD, Hamilton, Nalo, PhD, Dubinett, Steven M., MD, Garon, Edward B., MD, Pietras, Richard J., MD, PhD

Get full text